Evidence-Based Blood Management (Video)
World's Largest Resource for Cardiovascular Perfusion
Findings from two studies by the US Centers for Disease Control and Prevention indicate that the prevalence of overweight and obesity in […]
We herein report a rare case of cardiac and abdominal aortic inflammatory pseudotumors (IPTs). The pathological diagnosis was IPT, which was judged to be inoperable because of its anatomical location and the fact that the patient was a Jehovah's Witness, which precluded the administration of heterologous blood transfusions.
Terumo Americas Holding, Inc., a U.S. subsidiary of Japan’s Terumo Corporation, one of the world’s leading medical device manufacturers with $3.4 billion in sales and operations in more than 160 nations, today announced that it has entered into a Stock Purchase Agreement to acquire all outstanding shares of Harvest Technologies Corporation, an innovative biotechnology company working to commercialize the world’s first point-of-care technology that allows physicians to derive highly concentrated autologous, adult stem cells from their patients in just 15 minutes.